Save money on insulin from value or subscription plans.
Find details on insurance companies and pharmaceutical companies that provide plans that cap the monthly cost of insulin, provide value plans as well as subscription plans. The programs make it more affordable for people with or without commercial insurance. There is also a federal government assistance program for Medicare recipients that limited out-of-pocket costs for insulin. Learn how to save money on insulin each month.
The monthly, affordable insulin subscription plans from Sanofi, Eli Lilly, and Novo Nordisk benefit millions of patients. More than 30 million Americans face the daily challenge of dealing with Type 1 or Type 2 diabetes. About 25% require insulin to control high blood sugar levels, according to the American Diabetes Association. These value plans, discounts, and other benefits will help patients who have no health insurance save money as well as the low-income or diabetes. Or look here for details on totally free diabetic supplies.
Subscription plans and discounted insulin programs
Drug companies Eli Lilly, Sanofi and Novo Nordisk have controlled the insulin market for decades. They are now offer additional assistance to anyone that needs it, including low income families as well as the uninsured. Over the previous decades, the price of the most popular insulins had tripled. Now, the three major producers have services to which people could essentially subscribe and obtain a flat monthly fee for insulin products.
The drug company programs allow a person to register online and download a co-pay savings card that can be presented at pharmacies when insulin prescriptions are filled. The service can save most families hundreds of dollars per month.
Several affordable patient assistance programs, discounts, and monthly subscription services are available to persons regardless of income level. This can be particularly helpful to individuals who have insurance coverage with a high deductible or who do not qualify for low-income patient assistance programs offered by drug companies.
The Eli Lilly Company, a drug manufacturer, created the Lilly Insulin Value Program that provides a month's supply of insulin for $35. The program is available to uninsured individuals and those who have commercial insurance or coverage through Medicaid. All Lilly insulins including Humalog are available from the fixed monthly cost plan regardless of the number of vials or pens needed.
A co-pay card that can be presented to the pharmacy when you pick up your insulin prescription can be downloaded from Lilly's website at www.insulinaffordability.com. Although co-pay cards are not available to seniors who have Medicare Part D prescription drug plans, the same $35 cost cap may apply via Medicare's Senior Savings Model program for seniors enrolled in a qualifying Part D plan.
Novo Nordisk has a program called My$99Insulin. Eligible persons pay $99 to receive a monthly supply of insulin. Any combination of Novo Nordisk insulin products can be obtained with a limit of three vials or two packs of pens. The cost cannot be applied to any insurance deductible or Medicare out-of-pocket costs.
The program is available to uninsured persons and those with commercial insurance. Persons who have not been enrolled in the program and who receive prescription drug benefits via Medicare, VA, Medicaid, or other state and federal health programs are not eligible to enroll.
Once enrolled, the savings offer is good through the calendar year. Available products include Novolog, Levemir, Tresiba and Novolin.
Similar to the Lilly program, individuals can register online and download a card that can be redeemed at most retail pharmacies to obtain a monthly supply of insulin. For more information, go to the NovoCare website at www.novocare.com/insulin/my99insulin.html.
The Sanofi Insulins Valyou Savings Program will help low-income families, people with no insurance or those on Medicare save money. The drug company is a global pharmaceutical company, offers two programs to provide insulin at a low cost. Persons with insurance, regardless of income level, may be eligible for a co-pay assistance program which is a monthly subscription type service that makes the products more affordable. Most people in this program will pay no more than $10 for a month's supply of insulin.
For those who are uninsured, Sanofi initiated an Insulins Valyou Savings Program in 2018 and then expanded it a year later. For a monthly fee of $99, individuals receive up to 10 boxes of pens and/or 10 mL vials per month of Sanofi insulins. This program is also available to everyone regardless of income level. However, it is not available to persons insured under Medicare, Medicaid, or similar state and federal programs.
The program is available at U.S. pharmacies. As with other programs, you can register online to receive a co-pay savings card. Insulin products covered include Lantus, Toujeo, Apidra, and Admelog. For more information, visit the website at https://www.teamingupfordiabetes.com/sanofidiabetes-savings-program..
Cigna, a healthcare and insurance company, operates a Patient Assurance Program in partnership with Express Scripts that provides a 30-day supply of insulin for no more than a $25 out-of-pocket cost. Express Scripts is an online pharmacy and the pharmacy benefit management unit for Cigna.
The discount program covers all manufacturers, including Sanofi, Eli Lilly, and Novo Nordisk. Anyone whp gets their insurance or medications from those companies can get help from them. Insulin products manufactured by Lilly, Novo Nordisk, and Sanofi are available through the program.
The Patient Assurance Program is available to all Express Scripts consumers who are not enrolled in a government-funded insurance program. Persons may have Express Scripts prescription benefits through an employer, a health plan, or as part of Medicare Part D coverage.
Medicare's Insulin Senior Savings Model Program
Most of the subscription-type insulin savings programs are not available to persons covered by Medicare. The federal government will provide the elderly and/or disabled with financial assistance to help pay for insulin. More than 3 million Medicare beneficiaries require insulin. Research indicates that many seniors tend to stop taking insulin or take less than a full dose when the monthly co-pay reaches $50.
Public assistance is available. The Centers for Medicare and Medicaid Services (CMS) offer help from the Part D Senior Savings Model program. The federal government allows insurance companies who offer Medicare Part D prescription insurance plans to include a month's supply of insulin from participating manufacturers for no more than a $35 co-pay per month. CMS estimates the program provides an annual savings of $446 for most insulin users. Learn more on Medicare Part D and how to select a plan.
To obtain this benefit a person must be enrolled in a participating enhanced stand-alone or Medicare Advantage Part D drug plan. Nearly 100 health insurers agreed to participate in the program. This means tens of millions of people have access to affordable insulin from the Medicare benefit.
For example, using the Senior Savings Model, Humana now offers an Insulin Savings Program with some of its Medicare Advantage plans and all of its Premiere RX prescription drug plans. Eligible members pay $35 at in-network pharmacies for a month's supply of insulin. Some plans include co-pay amounts as low as $0. Other major Part D providers offering similar coverage include Aetna, United Healthcare, and Blue Cross.
Save money on insulin
The regular use of insulin remains essential for millions of Americans. The high cost of insulin is forcing many people to choose between taking the medication or skipping doses and risking serious health problems to pay rent or put food on the table. Today, as a result of these cost-capping programs and free to enroll insulin saving plans, fewer people face that difficult choice, and more people are living healthier lives.
Related Content From Needhelppayingbills.com
|
